JASON CROWLEY: Open Payments
NPI 1871862565 · SOUTH LAKE TAHOE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 7 payments from 7 companies in 2025. Trend: 2023 $169 · 2024 $66 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $34 |
| Novo Nordisk Inc | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| Dexcom, Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Abbott Laboratories | 1 | $17 |
Products named: VRAYLAR, Wegovy, MOUNJARO, Dexcom G6 Transmitter, JOURNAVX, FREESTYLE LIBRE 3.
Industry payments across CA — which companies pay providers there.
